We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+0.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.31B
AUM Growth
+$193M
Cap. Flow
+$48.1M
Cap. Flow %
1.45%
Top 10 Hldgs %
21.18%
Holding
236
New
17
Increased
85
Reduced
110
Closed
13

Top Sells

Rank Stock Value
1
HRI icon
Herc Holdings
HRI
+$24.8M
2
MMM icon
3M
MMM
+$13.2M
3
KO icon
Coca-Cola
KO
+$8.52M
4
DIS icon
Walt Disney
DIS
+$3.4M
5
DAL icon
Delta Air Lines
DAL
+$3.31M

Sector Composition

Rank Sector Weight
1 Industrials 19.48%
2 Technology 15.91%
3 Healthcare 15.1%
4 Consumer Discretionary 11.63%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAY
26
DELISTED
Verifone Systems Inc
PAY
$41.8M 1.26%
1,136,041
-44,765
-4% -$1.53M
TMO icon
27
Thermo Fisher Scientific
TMO
$213B
$41M 1.24%
347,038
-5,471
-2% -$644K
AL
28
DELISTED
Air Lease Corp
AL
$39.7M 1.2%
1,030,265
+26,930
+3% +$1.03M
EQIX icon
29
Equinix
EQIX
$101B
$39.5M 1.19%
187,826
+12,210
+7% +$2.35M
ECL icon
30
Ecolab
ECL
$78.1B
$38.1M 1.15%
341,833
-2,416
-0.7% -$259K
APTV icon
31
Aptiv
APTV
$12B
$37.9M 1.14%
551,084
+6,003
+1% +$407K
XRAY icon
32
Dentsply Sirona
XRAY
$2.68B
$37.3M 1.13%
787,880
-2,333
-0.3% -$109K
PEP icon
33
PepsiCo
PEP
$190B
$35.2M 1.06%
394,067
+4,895
+1% +$423K
SRCL
34
DELISTED
Stericycle Inc
SRCL
$34.9M 1.06%
294,887
+3,644
+1% +$417K
CERN
35
DELISTED
Cerner Corp
CERN
$34M 1.03%
659,772
+29,944
+5% +$1.57M
VTR icon
36
Ventas
VTR
$48B
$33.7M 1.02%
460,379
+9,949
+2% +$739K
PLD icon
37
Prologis
PLD
$135B
$33.7M 1.02%
819,300
+50,319
+7% +$2.07M
TGNA
38
DELISTED
TEGNA Inc
TGNA
$32.7M 0.99%
1,995,410
-48,062
-2% -$704K
VC icon
39
Visteon
VC
$2.79B
$32.6M 0.99%
336,451
+3,235
+1% +$294K
VRSK icon
40
Verisk Analytics
VRSK
$25.4B
$31.8M 0.96%
529,749
+96,925
+22% +$5.79M
MDLZ icon
41
Mondelez International
MDLZ
$79.5B
$30.6M 0.92%
813,211
-1,087
-0.1% -$39.7K
ABT icon
42
Abbott
ABT
$183B
$30M 0.91%
733,969
-15,837
-2% -$622K
PX
43
DELISTED
Praxair Inc
PX
$29.7M 0.9%
223,876
-2,398
-1% -$314K
VYX icon
44
NCR Voyix
VYX
$1.14B
$29.6M 0.89%
+1,372,810
New +$27.7M
DEO icon
45
Diageo
DEO
$49B
$29.2M 0.88%
229,520
+21,165
+10% +$2.67M
INTC icon
46
Intel
INTC
$455B
$29.2M 0.88%
944,970
+2,862
+0.3% +$78.4K
AMT icon
47
American Tower
AMT
$80.8B
$28.9M 0.87%
321,729
+8,508
+3% +$736K
CELG
48
DELISTED
Celgene Corp
CELG
$28.4M 0.86%
330,279
+112,441
+52% +$8.55M
LUX
49
DELISTED
Luxottica Group
LUX
$27.8M 0.84%
479,603
-1,975
-0.4% -$112K
APD icon
50
Air Products & Chemicals
APD
$65.7B
$27.7M 0.84%
233,002
-5,704
-2% -$636K

Similar funds

Douglas C. Lane & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Douglas C. Lane & Associates held 236 positions worth $3.31B, up 6.2% from $3.12B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas C. Lane & Associates's Q2 2014 filing shows 17 new, 85 increased, 110 reduced and 13 closed positions. Its largest new stake was Alphabet (Google) Class C: 1,931,168 shares worth $55.8M. The largest sale was Herc Holdings, an estimated $24.8M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q2 2014 buy was Alphabet (Google) Class C: 1,931,168 shares worth $55.8M.
  • Douglas C. Lane & Associates added most to XPO in Q2 2014, an estimated $10.6M increase.
  • Douglas C. Lane & Associates's biggest Q2 2014 reduction was Herc Holdings, cutting an estimated $24.8M.
  • Douglas C. Lane & Associates fully exited Energy Transfer Partners in Q2 2014, selling an estimated $273K.
  • Douglas C. Lane & Associates's ten largest holdings make up 21% of its $3.31B portfolio in Q2 2014.
  • Douglas C. Lane & Associates opened 17 new positions and closed 13 in Q2 2014.
  • Douglas C. Lane & Associates's portfolio value rose 6.2% quarter-over-quarter to $3.31B.

Based on Douglas C. Lane & Associates's 13F filing for Q2 2014, filed 11 Jul 2014.